Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
PLOS ONE ( IF 3.7 ) Pub Date : 2021-07-23 , DOI: 10.1371/journal.pone.0255429
PLOS ONE ( IF 3.7 ) Pub Date : 2021-07-23 , DOI: 10.1371/journal.pone.0255429
[This corrects the article DOI: 10.1371/journal.pone.0252041.].
中文翻译:
校正:利用靶病变异质性评估晚期肺癌的疗效。
[这更正了文章 DOI:10.1371/journal.pone.0252041.]。
更新日期:2021-07-23
中文翻译:
校正:利用靶病变异质性评估晚期肺癌的疗效。
[这更正了文章 DOI:10.1371/journal.pone.0252041.]。